Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors
CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 w...
Saved in:
Published in: | PloS one Vol. 9; no. 6; p. e100178 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
16-06-2014
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration. |
---|---|
AbstractList | CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue.sup.high /sera.sup.low -discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration. CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (s CSPG4 ) might circulate and reflect potential changes in CSPG4 tissue expression (p CSPG4 ) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum s CSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic p CSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. s CSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic p CSPG4 expression was preserved or elevated, whereby neoplastic cells lacked p CSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue high /sera low -discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which p VHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined p CSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed p CSPG4 -responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4 , is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic ‘drop and restoration’ alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration. CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration. CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+26) and patients with chronic pancreatitis (n = 11+20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissuehigh/seralow-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently non-pathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic ‘drop and restoration’ alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration. |
Audience | Academic |
Author | Titov, Alexandr Tjaden, Christine Gaida, Matthias M Werner, Jens Giese, Thomas Ahmad, Sufian S Keleg, Shereen Heller, Anette Bauer, Andrea S Giese, Nathalia A |
AuthorAffiliation | 4 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany The Liverpool Cancer Research UK Centre, United Kingdom 2 Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany 3 Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany 1 European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany |
AuthorAffiliation_xml | – name: 4 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany – name: 3 Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany – name: 2 Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany – name: 1 European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – name: The Liverpool Cancer Research UK Centre, United Kingdom |
Author_xml | – sequence: 1 givenname: Shereen surname: Keleg fullname: Keleg, Shereen organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 2 givenname: Alexandr surname: Titov fullname: Titov, Alexandr organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 3 givenname: Anette surname: Heller fullname: Heller, Anette organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 4 givenname: Thomas surname: Giese fullname: Giese, Thomas organization: Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany – sequence: 5 givenname: Christine surname: Tjaden fullname: Tjaden, Christine organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 6 givenname: Sufian S surname: Ahmad fullname: Ahmad, Sufian S organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 7 givenname: Matthias M surname: Gaida fullname: Gaida, Matthias M organization: Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany – sequence: 8 givenname: Andrea S surname: Bauer fullname: Bauer, Andrea S organization: Department of Functional Genomics, German Cancer Research Centre, Heidelberg, Germany – sequence: 9 givenname: Jens surname: Werner fullname: Werner, Jens organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany – sequence: 10 givenname: Nathalia A surname: Giese fullname: Giese, Nathalia A organization: European Pancreas Centre, Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24932730$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk11v0zAUhiM0xD7gHyCIhITgosWOndi5QZoqGJUmDTHg1nKck9bFtTPbqbZ_j7tmU4t2gXzh6Pg573l94nOaHVlnIcteYzTFhOFPKzd4K820T-Epwghhxp9lJ7gmxaQqEDna-z7OTkNYIVQSXlUvsuOCphNG0EkmZktnW-901DYPg-lkhLz3LoJbmDslbT67_n5BcxlymVu3AZMv73p3q-UkgA0pbQP5Wvo_4POk0EurPMioVR6HtfPhZfa8kybAq3E_y359_fJz9m1yeXUxn51fThQreUwmVbJZlbikkgHwpuNNQxkvaFVIWtWNojUgDsCA0bpoGSGMc2hwxyuCqCRn2dudbm9cEGNvgsAlqRCvS14kYr4jWidXovc6ub4TTmpxH3B-IaRPxg2IUgGgsu4ahQgt65YnCcbbNnmtgdfbap_HakOzhlaBjV6aA9HDE6uXYuE2giZZRrdmPowC3t0MEKJY66DAGGnBDfe-GU4gogl99w_69O1GaiHTBbTtXKqrtqLinGJOi7RwoqZPUGm1sNYqPaROp_hBwseDhMREuI0LOYQg5tc__p-9-n3Ivt9jlyBNXAZnhqidDYcg3YHKuxA8dI9Nxkhs5-ChG2I7B2Kcg5T2Zv8HPSY9PHzyF8z2A9Q |
CitedBy_id | crossref_primary_10_3390_cancers14225564 crossref_primary_10_1016_j_jprot_2018_07_015 crossref_primary_10_1021_acs_chemrev_8b00354 crossref_primary_10_18632_oncotarget_24312 crossref_primary_10_3390_vaccines10071023 crossref_primary_10_1371_journal_ppat_1011272 crossref_primary_10_2183_pjab_100_019 crossref_primary_10_1186_s11658_017_0035_3 crossref_primary_10_1371_journal_pone_0145584 crossref_primary_10_1186_s12896_015_0218_9 crossref_primary_10_1186_s12967_022_03679_y crossref_primary_10_1002_ijc_31087 crossref_primary_10_1016_j_ctrv_2021_102193 crossref_primary_10_1016_j_matbio_2017_10_008 crossref_primary_10_1177_03009858241244853 crossref_primary_10_1186_s12967_017_1250_4 crossref_primary_10_3892_ol_2023_13968 crossref_primary_10_1038_s41598_023_32528_1 |
Cites_doi | 10.1038/nrgastro.2011.114 10.1097/mpa.0b013e31805d0190 10.1016/S0140-6736(03)13643-4 10.1073/pnas.0900465106 10.1159/000147846 10.1016/j.cgh.2008.05.006 10.1371/journal.pone.0023062 10.1053/j.gastro.2007.01.031 10.1126/science.1195300 10.1023/A:1025731428581 10.1007/s00535-011-0482-y 10.1016/j.tibs.2012.06.004 10.1182/blood.V87.3.1123.bloodjournal8731123 10.1053/j.gastro.2012.03.002 10.1091/mbc.6.12.1819 10.1016/S0002-9440(10)63971-5 10.1038/372679a0 10.1158/1078-0432.CCR-13-2218 10.1073/pnas.1312570111 10.3109/14653249.2011.651528 10.1016/j.ccr.2007.02.020 10.1097/01.MP.0000094088.37888.A6 10.1053/j.gastro.2008.09.029 10.1242/dev.00837 10.4161/isl.2.3.11449 10.1073/pnas.0912589107 10.1016/0016-5085(91)90026-H 10.1016/S0002-9440(10)64799-2 10.1007/s00401-011-0867-2 10.1097/SLA.0b013e31828cd008 10.1038/nm.2344 10.1073/pnas.1001296107 10.1159/000094833 10.1007/s00428-004-1053-x 10.18632/oncotarget.1291 10.1016/S0002-9440(10)63053-2 10.1371/journal.pone.0084883 10.1097/SLA.0b013e31821fd334 10.1136/gut.2010.232272 10.1007/s00109-009-0504-x 10.1038/nrc3183 10.2174/13816128112092395 10.1016/j.devcel.2011.07.001 10.1016/j.surg.2011.05.011 10.1128/MCB.01621-07 10.1002/path.2348 10.1111/j.1741-4520.2010.00307.x 10.1016/S0016-5085(98)70209-4 10.1073/pnas.0810097105 10.1136/gut.2010.226092 10.1038/onc.2008.157 10.1016/j.ccr.2005.07.015 10.1097/01.MP.0000075645.97329.86 10.1167/iovs.05-0559 10.1016/j.pan.2012.04.004 10.1158/1078-0432.CCR-1190-03 10.1371/journal.pbio.1001143 10.1002/path.3017 10.1053/j.gastro.2007.09.009 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 Public Library of Science 2014 Keleg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Keleg et al 2014 Keleg et al |
Copyright_xml | – notice: COPYRIGHT 2014 Public Library of Science – notice: 2014 Keleg et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Keleg et al 2014 Keleg et al |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0100178 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Gale in Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Technology Collection ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest Engineering Database Nursing & Allied Health Premium ProQuest Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | CSPG4 in Pancreatic Tumors |
EISSN | 1932-6203 |
Editor | Costello, Eithne |
Editor_xml | – sequence: 1 givenname: Eithne surname: Costello fullname: Costello, Eithne |
EndPage | e100178 |
ExternalDocumentID | 1536089582 oai_doaj_org_article_5cee059fbc03459d808978ddc759e89a 3335849471 A418424241 10_1371_journal_pone_0100178 24932730 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RIG RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX CITATION AFPKN 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI PRINS RC3 7X8 5PM AAPBV ABPTK N95 |
ID | FETCH-LOGICAL-c758t-62c20365154a7ee8bf8bb4782462a469bc49e08ee7e7492d733788eb1f86304a3 |
IEDL.DBID | RPM |
ISSN | 1932-6203 |
IngestDate | Sun Apr 02 01:15:41 EDT 2023 Tue Oct 22 15:06:38 EDT 2024 Tue Sep 17 20:45:21 EDT 2024 Fri Oct 25 09:22:12 EDT 2024 Thu Oct 10 20:34:31 EDT 2024 Tue Nov 19 20:39:51 EST 2024 Tue Nov 12 22:34:37 EST 2024 Thu Aug 01 20:24:19 EDT 2024 Thu Aug 01 19:35:39 EDT 2024 Tue Aug 20 22:05:03 EDT 2024 Thu Nov 21 22:45:01 EST 2024 Tue Oct 15 23:50:16 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c758t-62c20365154a7ee8bf8bb4782462a469bc49e08ee7e7492d733788eb1f86304a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: SK AT AH CT JW NAG. Performed the experiments: SK AT AH TG SSA NAG. Analyzed the data: SK AT MMG JW NAG. Contributed reagents/materials/analysis tools: TG ASB CT JW. Wrote the paper: SK NAG. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059742/ |
PMID | 24932730 |
PQID | 1536089582 |
PQPubID | 1436336 |
ParticipantIDs | plos_journals_1536089582 doaj_primary_oai_doaj_org_article_5cee059fbc03459d808978ddc759e89a pubmedcentral_primary_oai_pubmedcentral_nih_gov_4059742 proquest_miscellaneous_1537174204 proquest_journals_1536089582 gale_infotracmisc_A418424241 gale_infotracacademiconefile_A418424241 gale_incontextgauss_ISR_A418424241 gale_incontextgauss_IOV_A418424241 gale_healthsolutions_A418424241 crossref_primary_10_1371_journal_pone_0100178 pubmed_primary_24932730 |
PublicationCentury | 2000 |
PublicationDate | 2014-06-16 |
PublicationDateYYYYMMDD | 2014-06-16 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2014 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | 23532108 - Ann Surg. 2013 Jul;258(1):141-51 20966025 - Gut. 2011 Jun;60(6):861-8 20660313 - Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14182-7 14501214 - J Neurocytol. 2002 Jul-Aug;31(6-7):423-35 21750515 - Nat Rev Gastroenterol Hepatol. 2011 Aug;8(8):467-72 18227155 - Mol Cell Biol. 2008 Apr;28(7):2414-25 18054571 - Gastroenterology. 2007 Dec;133(6):1999-2009 12814730 - Lancet. 2003 Jun 14;361(9374):2059-67 2065922 - Gastroenterology. 1991 Aug;101(2):465-71 15258755 - Virchows Arch. 2004 Sep;445(3):236-47 17895840 - Pancreas. 2007 Oct;35(3):212-7 17408641 - Gastroenterology. 2007 Apr;132(4):1447-64 21984419 - J Pathol. 2012 Apr;226(5):723-34 22687371 - Pancreatology. 2012 May-Jun;12(3):183-97 22169972 - Nat Rev Cancer. 2012 Jan;12(1):9-22 19629420 - J Mol Med (Berl). 2009 Sep;87(9):871-7 18469852 - Oncogene. 2008 Sep 4;27(39):5182-94 21508421 - Gut. 2011 Dec;60(12):1712-20 22406637 - Gastroenterology. 2012 May;142(5):1079-92 16888406 - Ophthalmic Res. 2006;38(5):251-4 19541609 - Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11137-42 18992743 - Gastroenterology. 2009 Jan;136(1):177-186.e1 8669463 - Am J Pathol. 1996 Jun;148(6):1763-70 21606835 - Ann Surg. 2011 Aug;254(2):311-9 21909240 - PLoS Biol. 2011 Sep;9(9):e1001143 24334762 - Clin Cancer Res. 2014 Feb 15;20(4):962-71 24604757 - J Pathol. 2014 Jul;233(3):217-27 18639493 - Clin Gastroenterol Hepatol. 2008 Oct;6(10):1155-61 23474557 - JOP. 2013 Mar;14(2):141-4 16169464 - Cancer Cell. 2005 Sep;8(3):185-95 9679048 - Gastroenterology. 1998 Aug;115(2):421-32 24127551 - Oncotarget. 2013 Sep;4(9):1527-46 21099310 - Islets. 2010 May-Jun;2(3):164-73 11141506 - Am J Pathol. 2001 Jan;158(1):317-21 7990960 - Nature. 1994 Dec 15;372(6507):679-83 22041919 - J Gastroenterol. 2012 Feb;47(2):203-13 22699001 - Eur J Cell Biol. 2012 Nov-Dec;91(11-12):969-77 18421760 - J Pathol. 2008 Jun;215(2):195-203 21051638 - Science. 2010 Nov 5;330(6005):827-30 9117258 - Perspect Dev Neurobiol. 1996;3(4):245-59 9124036 - Acta Anat (Basel). 1996;156(3):187-201 17349578 - Cancer Cell. 2007 Mar;11(3):211-3 21719059 - Surgery. 2011 Aug;150(2):306-15 11733352 - Am J Pathol. 2001 Dec;159(6):2017-22 21129040 - Congenit Anom (Kyoto). 2011 Mar;51(1):21-5 21829586 - PLoS One. 2011;6(7):e23062 14573520 - Development. 2003 Dec;130(24):6049-63 22277011 - Cytotherapy. 2012 May;14(5):608-20 22372500 - Curr Pharm Des. 2012;18(17):2395-403 21839917 - Dev Cell. 2011 Aug 16;21(2):193-215 12861065 - Mod Pathol. 2003 Jul;16(7):686-91 15269152 - Clin Cancer Res. 2004 Jul 15;10(14):4776-83 8590808 - Mol Biol Cell. 1995 Dec;6(12):1819-32 16303921 - Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4365-71 21460848 - Nat Med. 2011 Apr;17(4):500-3 22818162 - Trends Biochem Sci. 2012 Sep;37(9):364-72 24386429 - PLoS One. 2013;8(12):e84883 21863242 - Acta Neuropathol. 2011 Oct;122(4):495-510 14614047 - Mod Pathol. 2003 Nov;16(11):1086-94 20018761 - Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):75-80 24550282 - Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2554-9 11073821 - Am J Pathol. 2000 Nov;157(5):1615-21 8562938 - Blood. 1996 Feb 1;87(3):1123-33 19028870 - Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8 Y Li (ref17) 2005; 46 F Girolamo (ref19) 2013; 8 GO Ceyhan (ref3) 2009; 136 EA Collisson (ref38) 2011; 17 B Faubert (ref37) 2014; 111 O Strobel (ref45) 2007; 133 SG Kim (ref59) 2003; 16 A Armulik (ref6) 2011; 21 D Pankova (ref13) 2012 HP Neumann (ref33) 1991; 101 M Erkan (ref2) 2008; 6 RR Lonser (ref52) 2003; 361 M Erkan (ref23) 2007; 132 U Ozerdem (ref18) 2006; 38 J Koninger (ref24) 2004; 10 JM Levine (ref8) 1996; 3 J Legg (ref9) 2003; 130 F Carlotti (ref10) 2010; 2 A Neesse (ref21) 2011; 60 J Mazumdar (ref42) 2010; 107 A Poli (ref63) 2013; 4 M Chekenya (ref15) 2008; 27 M Kraman (ref5) 2010; 330 K Stark (ref54) 1994; 372 L Landsman (ref57) 2011; 9 LC Murtaugh (ref46) 2007; 11 A Nishiyama (ref20) 1995; 6 WB Stallcup (ref11) 2002; 31 E Amato (ref30) 2014 T Furukawa (ref25) 1996; 148 M Mino-Kenudson (ref27) 2011; 60 N Habbe (ref47) 2008; 105 C Geldres (ref64) 2014; 20 B Kong (ref43) 2011; 8 BZ Stanger (ref48) 2005; 8 M Tanaka (ref28) 2012; 12 H Arafat (ref32) 2011; 150 Y Higuchi (ref58) 2011; 51 F Konstantinou (ref29) 2013; 14 PS Moore (ref60) 2001; 158 M Bartel (ref26) 2008; 215 FO Smith (ref12) 1996; 87 MG Bachem (ref22) 1998; 115 J Wang (ref16) 2011; 6 I Esposito (ref50) 2007; 35 MY Koh (ref41) 2012; 37 PA Perez-Mancera (ref44) 2012; 142 M Aichler (ref49) 2012; 226 MS Wiesener (ref53) 2009; 87 M Rovira (ref51) 2010; 107 N Ideno (ref39) 2013; 258 D Mohri (ref31) 2012; 47 VH Mohr (ref34) 2000; 157 DB Shackelford (ref36) 2009; 106 B Keith (ref40) 2012; 12 N Sato (ref61) 2001; 159 AF Hezel (ref35) 2008; 28 H Liu (ref4) 2012; 18 PJ Ju (ref7) 2012; 14 A Svendsen (ref14) 2011; 122 JA Davies (ref55) 1996; 156 F Sahin (ref62) 2003; 16 P Monti (ref56) 2004; 445 W Hartwig (ref1) 2011; 254 |
References_xml | – volume: 8 start-page: 467 year: 2011 ident: ref43 article-title: From tissue turnover to the cell of origin for pancreatic cancer publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2011.114 contributor: fullname: B Kong – volume: 35 start-page: 212 year: 2007 ident: ref50 article-title: Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment publication-title: Pancreas doi: 10.1097/mpa.0b013e31805d0190 contributor: fullname: I Esposito – volume: 361 start-page: 2059 year: 2003 ident: ref52 article-title: von Hippel-Lindau disease publication-title: Lancet doi: 10.1016/S0140-6736(03)13643-4 contributor: fullname: RR Lonser – volume: 106 start-page: 11137 year: 2009 ident: ref36 article-title: mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0900465106 contributor: fullname: DB Shackelford – volume: 156 start-page: 187 year: 1996 ident: ref55 article-title: Mesenchyme to epithelium transition during development of the mammalian kidney tubule publication-title: Acta Anat (Basel) doi: 10.1159/000147846 contributor: fullname: JA Davies – volume: 6 start-page: 1155 year: 2008 ident: ref2 article-title: The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2008.05.006 contributor: fullname: M Erkan – volume: 6 start-page: e23062 year: 2011 ident: ref16 article-title: Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma publication-title: PLoS One doi: 10.1371/journal.pone.0023062 contributor: fullname: J Wang – volume: 132 start-page: 1447 year: 2007 ident: ref23 article-title: Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.01.031 contributor: fullname: M Erkan – volume: 330 start-page: 827 year: 2010 ident: ref5 article-title: Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha publication-title: Science doi: 10.1126/science.1195300 contributor: fullname: M Kraman – volume: 31 start-page: 423 year: 2002 ident: ref11 article-title: The NG2 proteoglycan: past insights and future prospects publication-title: J Neurocytol doi: 10.1023/A:1025731428581 contributor: fullname: WB Stallcup – volume: 47 start-page: 203 year: 2012 ident: ref31 article-title: Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression publication-title: J Gastroenterol doi: 10.1007/s00535-011-0482-y contributor: fullname: D Mohri – volume: 37 start-page: 364 year: 2012 ident: ref41 article-title: Passing the baton: the HIF switch publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2012.06.004 contributor: fullname: MY Koh – volume: 87 start-page: 1123 year: 1996 ident: ref12 article-title: The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23 publication-title: Blood doi: 10.1182/blood.V87.3.1123.bloodjournal8731123 contributor: fullname: FO Smith – volume: 142 start-page: 1079 year: 2012 ident: ref44 article-title: What we have learned about pancreatic cancer from mouse models publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.03.002 contributor: fullname: PA Perez-Mancera – volume: 6 start-page: 1819 year: 1995 ident: ref20 article-title: Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis publication-title: Mol Biol Cell doi: 10.1091/mbc.6.12.1819 contributor: fullname: A Nishiyama – volume: 158 start-page: 317 year: 2001 ident: ref60 article-title: Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63971-5 contributor: fullname: PS Moore – volume: 372 start-page: 679 year: 1994 ident: ref54 article-title: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4 publication-title: Nature doi: 10.1038/372679a0 contributor: fullname: K Stark – volume: 20 start-page: 962 year: 2014 ident: ref64 article-title: T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-2218 contributor: fullname: C Geldres – volume: 111 start-page: 2554 year: 2014 ident: ref37 article-title: Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1312570111 contributor: fullname: B Faubert – volume: 14 start-page: 608 year: 2012 ident: ref7 article-title: Clonal analysis for elucidating the lineage potential of embryonic NG2+ cells publication-title: Cytotherapy doi: 10.3109/14653249.2011.651528 contributor: fullname: PJ Ju – volume: 11 start-page: 211 year: 2007 ident: ref46 article-title: A case of mistaken identity? Nonductal origins of pancreatic “ductal” cancers publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.02.020 contributor: fullname: LC Murtaugh – volume: 16 start-page: 1086 year: 2003 ident: ref59 article-title: Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas publication-title: Mod Pathol doi: 10.1097/01.MP.0000094088.37888.A6 contributor: fullname: SG Kim – volume: 136 start-page: 177 year: 2009 ident: ref3 article-title: Pancreatic neuropathy and neuropathic pain–a comprehensive pathomorphological study of 546 cases publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.09.029 contributor: fullname: GO Ceyhan – volume: 130 start-page: 6049 year: 2003 ident: ref9 article-title: Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis publication-title: Development doi: 10.1242/dev.00837 contributor: fullname: J Legg – volume: 2 start-page: 164 year: 2010 ident: ref10 article-title: Isolated human islets contain a distinct population of mesenchymal stem cells publication-title: Islets doi: 10.4161/isl.2.3.11449 contributor: fullname: F Carlotti – volume: 107 start-page: 75 year: 2010 ident: ref51 article-title: Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0912589107 contributor: fullname: M Rovira – volume: 101 start-page: 465 year: 1991 ident: ref33 article-title: Pancreatic lesions in the von Hippel-Lindau syndrome publication-title: Gastroenterology doi: 10.1016/0016-5085(91)90026-H contributor: fullname: HP Neumann – volume: 157 start-page: 1615 year: 2000 ident: ref34 article-title: Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64799-2 contributor: fullname: VH Mohr – volume: 122 start-page: 495 year: 2011 ident: ref14 article-title: Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0867-2 contributor: fullname: A Svendsen – volume: 258 start-page: 141 year: 2013 ident: ref39 article-title: Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype publication-title: Ann Surg doi: 10.1097/SLA.0b013e31828cd008 contributor: fullname: N Ideno – volume: 17 start-page: 500 year: 2011 ident: ref38 article-title: Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy publication-title: Nat Med doi: 10.1038/nm.2344 contributor: fullname: EA Collisson – volume: 107 start-page: 14182 year: 2010 ident: ref42 article-title: HIF-2alpha deletion promotes Kras-driven lung tumor development publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1001296107 contributor: fullname: J Mazumdar – volume: 38 start-page: 251 year: 2006 ident: ref18 article-title: Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse publication-title: Ophthalmic Res doi: 10.1159/000094833 contributor: fullname: U Ozerdem – volume: 445 start-page: 236 year: 2004 ident: ref56 article-title: A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile publication-title: Virchows Arch doi: 10.1007/s00428-004-1053-x contributor: fullname: P Monti – volume: 3 start-page: 245 year: 1996 ident: ref8 article-title: The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells publication-title: Perspect Dev Neurobiol contributor: fullname: JM Levine – volume: 4 start-page: 1527 year: 2013 ident: ref63 article-title: Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival publication-title: Oncotarget doi: 10.18632/oncotarget.1291 contributor: fullname: A Poli – volume: 159 start-page: 2017 year: 2001 ident: ref61 article-title: STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63053-2 contributor: fullname: N Sato – volume: 8 start-page: e84883 year: 2013 ident: ref19 article-title: Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets publication-title: PLoS One doi: 10.1371/journal.pone.0084883 contributor: fullname: F Girolamo – volume: 254 start-page: 311 year: 2011 ident: ref1 article-title: Pancreatic cancer surgery in the new millennium: better prediction of outcome publication-title: Ann Surg doi: 10.1097/SLA.0b013e31821fd334 contributor: fullname: W Hartwig – volume: 60 start-page: 1712 year: 2011 ident: ref27 article-title: Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes publication-title: Gut doi: 10.1136/gut.2010.232272 contributor: fullname: M Mino-Kenudson – volume: 87 start-page: 871 year: 2009 ident: ref53 article-title: Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression publication-title: J Mol Med (Berl) doi: 10.1007/s00109-009-0504-x contributor: fullname: MS Wiesener – volume: 12 start-page: 9 year: 2012 ident: ref40 article-title: HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression publication-title: Nat Rev Cancer doi: 10.1038/nrc3183 contributor: fullname: B Keith – volume: 18 start-page: 2395 year: 2012 ident: ref4 article-title: Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer publication-title: Curr Pharm Des doi: 10.2174/13816128112092395 contributor: fullname: H Liu – volume: 21 start-page: 193 year: 2011 ident: ref6 article-title: Pericytes: developmental, physiological, and pathological perspectives, problems, and promises publication-title: Dev Cell doi: 10.1016/j.devcel.2011.07.001 contributor: fullname: A Armulik – year: 2012 ident: ref13 article-title: NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells publication-title: Eur J Cell Biol contributor: fullname: D Pankova – volume: 150 start-page: 306 year: 2011 ident: ref32 article-title: Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer publication-title: Surgery doi: 10.1016/j.surg.2011.05.011 contributor: fullname: H Arafat – volume: 28 start-page: 2414 year: 2008 ident: ref35 article-title: Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms publication-title: Mol Cell Biol doi: 10.1128/MCB.01621-07 contributor: fullname: AF Hezel – volume: 215 start-page: 195 year: 2008 ident: ref26 article-title: Abnormal crosstalk between pancreatic acini and macrophages during the clearance of apoptotic cells in chronic pancreatitis publication-title: J Pathol doi: 10.1002/path.2348 contributor: fullname: M Bartel – volume: 51 start-page: 21 year: 2011 ident: ref58 article-title: In vitro models of pancreatic differentiation using embryonic stem or induced pluripotent stem cells publication-title: Congenit Anom (Kyoto) doi: 10.1111/j.1741-4520.2010.00307.x contributor: fullname: Y Higuchi – volume: 14 start-page: 141 year: 2013 ident: ref29 article-title: Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects publication-title: JOP contributor: fullname: F Konstantinou – year: 2014 ident: ref30 article-title: Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas publication-title: J Pathol contributor: fullname: E Amato – volume: 115 start-page: 421 year: 1998 ident: ref22 article-title: Identification, culture, and characterization of pancreatic stellate cells in rats and humans publication-title: Gastroenterology doi: 10.1016/S0016-5085(98)70209-4 contributor: fullname: MG Bachem – volume: 105 start-page: 18913 year: 2008 ident: ref47 article-title: Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0810097105 contributor: fullname: N Habbe – volume: 60 start-page: 861 year: 2011 ident: ref21 article-title: Stromal biology and therapy in pancreatic cancer publication-title: Gut doi: 10.1136/gut.2010.226092 contributor: fullname: A Neesse – volume: 27 start-page: 5182 year: 2008 ident: ref15 article-title: The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling publication-title: Oncogene doi: 10.1038/onc.2008.157 contributor: fullname: M Chekenya – volume: 8 start-page: 185 year: 2005 ident: ref48 article-title: Pten constrains centroacinar cell expansion and malignant transformation in the pancreas publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.07.015 contributor: fullname: BZ Stanger – volume: 16 start-page: 686 year: 2003 ident: ref62 article-title: Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms publication-title: Mod Pathol doi: 10.1097/01.MP.0000075645.97329.86 contributor: fullname: F Sahin – volume: 46 start-page: 4365 year: 2005 ident: ref17 article-title: In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0559 contributor: fullname: Y Li – volume: 12 start-page: 183 year: 2012 ident: ref28 article-title: International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas publication-title: Pancreatology doi: 10.1016/j.pan.2012.04.004 contributor: fullname: M Tanaka – volume: 10 start-page: 4776 year: 2004 ident: ref24 article-title: Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-1190-03 contributor: fullname: J Koninger – volume: 148 start-page: 1763 year: 1996 ident: ref25 article-title: Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16 publication-title: The American journal of pathology contributor: fullname: T Furukawa – volume: 9 start-page: e1001143 year: 2011 ident: ref57 article-title: Pancreatic mesenchyme regulates epithelial organogenesis throughout development publication-title: PLoS Biol doi: 10.1371/journal.pbio.1001143 contributor: fullname: L Landsman – volume: 226 start-page: 723 year: 2012 ident: ref49 article-title: Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues publication-title: J Pathol doi: 10.1002/path.3017 contributor: fullname: M Aichler – volume: 133 start-page: 1999 year: 2007 ident: ref45 article-title: In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.09.009 contributor: fullname: O Strobel |
SSID | ssj0053866 |
Score | 2.289422 |
Snippet | CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect... CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (s CSPG4 ) might circulate and reflect... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e100178 |
SubjectTerms | Aberration Adenocarcinoma, Mucinous - genetics Adenocarcinoma, Mucinous - metabolism Adenocarcinoma, Mucinous - pathology Adolescent Adult Aged Aged, 80 and over Benign Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Blotting, Western Carcinoma Carcinoma, Pancreatic Ductal - genetics Carcinoma, Pancreatic Ductal - metabolism Carcinoma, Pancreatic Ductal - pathology Carcinoma, Papillary - genetics Carcinoma, Papillary - metabolism Carcinoma, Papillary - pathology Chondroitin sulfate Chondroitin Sulfate Proteoglycans - genetics Chondroitin Sulfate Proteoglycans - metabolism Cloning Cystadenoma, Serous - genetics Cystadenoma, Serous - metabolism Cystadenoma, Serous - pathology Diagnostic systems Discordance Enzyme-Linked Immunosorbent Assay Epithelial cells Exploration Female Flow Cytometry Fluorescent Antibody Technique Follow-Up Studies Hospitals Humans Hypoxia Hypoxia - genetics Hypoxia - pathology Immunoenzyme Techniques Immunoglobulins Immunohistochemistry In vitro methods and tests Invasiveness Male Medicine and Health Sciences Melanoma Membrane Proteins - genetics Membrane Proteins - metabolism Mesenchyme Middle Aged Mutation Neoplasia Neoplasm Staging Neoplasms Pancreas Pancreatic cancer Pancreatic diseases Pancreatic Neoplasms - genetics Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Pancreatitis Patients Pericytes Polarity Prognosis Real-Time Polymerase Chain Reaction Restoration Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics Shedding Signaling siRNA Stroma Sulfates Surgery Tissue Array Analysis Tumor cell lines Tumor cells Tumor Cells, Cultured Tumors Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZgT1wQ5dWUAgYhAYe0TuK1nWNZWsoFEAuIm-U4TnelbbJabxD998zE2YigSnDgGk-iZF7-Rpn5TMgLwStbVkzFvKhMzG0uIKRSMIiwgEcNuIjF4eTzufzwXb09RZqc4agv7AkL9MBBccdTyOIAAarCsoxP81IxBYVPWVo5zZ3KAzRiYldMhRwMUSxEPyiXyeS4t8vRuqndEUu6M-lHG1HH1z9k5cl61fjrIOefnZO_bUVnd8jtHkPSk_Due-SGq--SvT5KPX3VU0m_vkf0bNEgI8Fyu6ypb1cVIEvaUTM0F6sr0CqdzT-949R4amjd_HArurhaNz-XJvbY2Y65kF5iB8-GwhMgcwSQaem2vWw2_j75enb6ZXYe90cqxKAvtY1FavHPI4AYbqRzqqhUUXBACVykBirlwvLcMeWcdJLnaSkz5JuHfF4pkTFusgdkUoMS9wmdqiJnRiaOS-T0MwUvs8KpEkm8TJKJiMQ7_ep1YM7Q3e8zCRVHUJRGe-jeHhF5g0YYZJH3ursA3qB7b9B_84aIPEUT6jBEOkSvPuFQyeIkTBKR550Ecl_U2FxzYVrv9fuP3_5BaP55JPSyF6oacAZr-oEG-Cbk1BpJHo4kIYLtaHkfHW6nFa9hFxLwYVOVwp07J7x--dmwjA_FhrnaNW0nA4U6TxmPyMPgs4NmoeLOALWyiMiRN49UP16pl4uOehzgPRSg6cH_sNUjcgvQJ8e-u0Qcksl207rH5KYv2yddMP8C8mZN6w priority: 102 providerName: Directory of Open Access Journals |
Title | Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24932730 https://www.proquest.com/docview/1536089582 https://search.proquest.com/docview/1537174204 https://pubmed.ncbi.nlm.nih.gov/PMC4059742 https://doaj.org/article/5cee059fbc03459d808978ddc759e89a http://dx.doi.org/10.1371/journal.pone.0100178 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdYT1wQ42sZYxiEBBzS5sO1neMoG-XAqOhA3CLHcbpKbVI1DWL_Pe85TrWgHRDX-CWK34f9e_F7vxDyhrNC50UgfZYVymc64RBSERiEa8CjClxEY3PydC4uf8qP50iTM-56YWzRvs6Ww3K1HpbLa1tbuVnrUVcnNpp9mQDIABgcjQ7IAWDDLkVvl18IYM5dj1wswpEzyXBTlWYYhPZ39MgAzAC4CKx9vrUdWdb-_do82Kyq-i7g-Xf95K0N6eIheeCQJD1r3_iQ3DPlI3LoYrWm7xyh9PvHJJ1cV8hLsNwtSzpvVgXgSzpDgoZqsboB3dLJfPaJUVVTRS-rX2ZFpzeb6vdS-XOsb8cVkWJTj9lSeMIMHMVCTU2vmnW1rZ-Q7xfnV5Op736s4GtID3Y-jzSePwKUYUoYI7NCZhkDrMB4pCBfzjRLTCCNEUawJMpFjKzzsKoXkscBU_FTMihBn0eEjmWWBEqEhglk9lMZy-PMyBypvFQYc4_4nX7TTcufkdpDNAF5R6uoFE2TOtN45AMaYS-L7Nf2QrVdpM4H0jHs7OACRaaDmI2TXAYSkuE8h9klRibKIy_RhGnbSrqP4fSMQT6L_TChR15bCWTAKLHEZqGauk4_f_3xD0Lzbz2ht06oqMAZtHJtDTAnZNbqSZ70JCGOdW_4CB2u00qdwl7EYWJjGcGdnRPePfxqP4wPxbK50lSNlYF0nUUB88iz1mf3mu0iwCOi58091fdHIB4tAbmLv-P_vvM5uQ_Ak2HJXchPyGC3bcwLclDnzan9KHJqQ_oPy3dN_g |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RcIALUF41FLogJODgxI_Nen0soSUVbYhIQNxW6_U6tZTYURwj-u-Z8SOqUQ-oV-_Y0s5rv5FnviXkHWeJjhNH2CxKlM10yCGkPDAI14BHFbiIxuHk8SyY_BKfT5AmZ9jOwlRN-zpK-9ly1c_Sy6q3cr3Sg7ZPbDC9GAHIABjsDfbIXYhXx2mL9DoBwyPOmyk5P3AHjVH66zwzfcetLqRHDmAG0CXA7udrB1LF27_Lzr31Mi9ugp7_dlBeO5JOH95yM4_IgwaD0uN6eZ_cMdljst9EeUE_NFTUH58QObrMkdEg3aYZnZXLBJApnSK1Q75YXoFV6Gg2_cKoKqiik_y3WdLx1Tr_kyp7hp3xmEspjgOZDYUvTMHFKpCq6bxc5ZviKflxejIfje3mSgZbQ2Gxtbmn8c8lgCCmAmNElIgoYoAyGPcUVNqRZqFxhDGBCVjoxYGPfPVwHiSC-w5T_jPSy8AOB4QORRQ6KnANC5ATUEUs9iMjYiQBU67PLWK3dpHrmnlDVr_fAqhYakVJNKlsTGqRT2i8nSzyZlcP8s1CNgqXQ8AEoO8k0o7PhmEsHAFldBzD7kIjQmWRIzS9rIdQd9EvjxlUwjhJ41rkbSWB3BkZNucsVFkU8uzbz_8Qmn3vCL1vhJIcnEirZiAC9oScXB3Jw44kZADdWT5AR221Ukg4xThsbCg8eLN13puX3-yW8aPYcJeZvKxkoNBnnsMs8rz29Z1m28ixSNCJgo7quyvg_BV1eePsL2795hG5N55fnMvzs8nXl-Q-wFeGjXsuPyS97aY0r8heEZevq4TwF4_GYpA |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RICEuQHnVUOiCkICD49fGXh9L2pAKCBEpFbfVer1OIyW2FceI_ntm_FKNekBw9Y4t7bz2G3nmW0Le-CxRcWJzk0WJNJkKfQgpFwziK8CjElxE4XDydBHMfvCTU6TJ6a76qpr2VbQapuvNMF1dVr2V-UZZbZ-YNf8yBpABMNi18jix9shtiFnbbQv1OgnDI99vJuW8wLEawwzzLNVD26kupUceYAbwJcAO6GuHUsXd32XoQb7Oipvg559dlNeOpcn9_9jQA3KvwaL0uBbZJ7d0-pDsN9Fe0HcNJfX7R0SMLzNkNljtVildlOsEECqdI8VDtlxfgXXoeDH_yKgsqKSz7Kde0-lVnv1aSXOBHfKYUymOBekthS_MwdUqsKroebnJtsVj8n1yej6ems3VDKaCAmNn-q7CP5gAhpgMtOZRwqOIAdpgviuh4o4UC7XNtQ50wEI3DjzkrYdzIeG-ZzPpPSGDFGxxQOiIR6EtA0ezALkBZcRiL9I8RjIw6Xi-QczWNiKvGThE9RsugMqlVpRAs4rGrAb5gAbsZJE_u3qQbZeiUboYATYAnSeRsj02CmNucyin4xh2F2oeSoMcoflFPYzaZQFxzKAixokaxyCvKwnk0EixSWcpy6IQZ18v_kJo8a0n9LYRSjJwJCWbwQjYE3Jz9SQPe5KQCVRv-QCdtdVKIeA082FjI-7Cm60D37z8qlvGj2LjXaqzspKBgp-5NjPI09rfO8220WOQoBcJPdX3VyAAKgrzxuGf_fObR-TO_GQiPp_NPj0ndwHFMuzfc_xDMthtS_2C7BVx-bLKCb8BpX5lEA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chondroitin+sulfate+proteoglycan+CSPG4+as+a+novel+hypoxia-sensitive+marker+in+pancreatic+tumors&rft.jtitle=PloS+one&rft.au=Keleg%2C+Shereen&rft.au=Titov%2C+Alexandr&rft.au=Heller%2C+Anette&rft.au=Giese%2C+Thomas&rft.date=2014-06-16&rft.eissn=1932-6203&rft.volume=9&rft.issue=6&rft.spage=e100178&rft.epage=e100178&rft_id=info:doi/10.1371%2Fjournal.pone.0100178&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |